The Team at Seroba
Daniel O’Mahony is a Partner at Seroba Life Sciences and brings a wealth of experience in product development, strategic planning, licensing, corporate venturing, intellectual property management and commercialization.
Daniel has been involved in corporate venture at Elan Corporation from 1996-2003; he was an advisor and consultant to Kernel Capital venture capital fund since 2001, focusing on investments in life sciences. He joined Kernel Capital as Partner in 2008 and joined Seroba as Partner in 2009.
Daniel graduated with a Ph.D. from the National University of Ireland, Cork in 1986 and holds a business degree in technology management from the Smurfit Business School, University College Dublin (2000). He has held academic appointments at the Genetics Department, Trinity College, Dublin, the Weis Research Centre, Geisinger Clinic, Pennsylvania, USA and the Department of Medicine & Experimental Therapeutics at University College. He has published in several scientific journals and is co-inventor on numerous patent families.
Daniel currently sits on the board of Apica Cardiovascular Ltd, Covagen AG, Novate Medical Ltd, PQ ByPass Inc and is a former board member of a number of companies. Recent exits include Apica which was acquired by Thoratec for $75m in July 2014 and Stokes Bio which was acquired by Life Technologies.< back to home page